General Announcement::ANNOUNCEMENT OF SETTLEMENT OF THE REPURCHASE EQUITY-LINKED SECURITIES DUE 2022

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
09-Oct-2018 21:58:17
Status
New
Announcement Sub Title
ANNOUNCEMENT OF SETTLEMENT OF THE REPURCHASE EQUITY-LINKED SECURITIES DUE 2022
Announcement Reference
SG181009OTHRSGXE
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary Compliance Officer
Effective Date and Time of the event
09/10/2018 17:00:00
Description (Please provide a detailed description of the event in the box below)
SUB: ANNOUNCEMENT OF SETTLEMENT OF THE REPURCHASE IN RESPECT OF THE COMPANY S U.S.$200,000,000 2.00 PER CENT. RESETTABLE ONWARD STARTING EQUITY-LINKED SECURITIES DUE 2022

With respect to the above subject, please find enclosed herewith Announcement of Settlement of the Repurchase.

You are requested to take the same on record.

Attachments

SGX_Settlement_09102018.pdf
Total size =3307K